BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29448871)

  • 1. Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters.
    Chedik L; Bruyere A; Fardel O
    Xenobiotica; 2019 Mar; 49(3):363-374. PubMed ID: 29448871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.
    Chedik L; Bruyere A; Le Vee M; Stieger B; Denizot C; Parmentier Y; Potin S; Fardel O
    PLoS One; 2017; 12(1):e0169480. PubMed ID: 28099443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential
    Bruyère A; Le Vée M; Jouan E; Molez S; Nies AT; Fardel O
    Xenobiotica; 2021 Apr; 51(4):467-478. PubMed ID: 33455503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
    Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of human solute carrier transporters by multikinase inhibitors.
    Johnston RA; Rawling T; Chan T; Zhou F; Murray M
    Drug Metab Dispos; 2014 Nov; 42(11):1851-7. PubMed ID: 25165131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC Family Transporters.
    Liu X
    Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SLC drug transporter activities by environmental bisphenols.
    Bruyere A; Hubert C; Le Vee M; Chedik L; Sayyed K; Stieger B; Denizot C; Parmentier Y; Fardel O
    Toxicol In Vitro; 2017 Apr; 40():34-44. PubMed ID: 27989701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the active components of Punica granatum (pomegranate) with the essential renal and hepatic human Solute Carrier transporters.
    Li Z; Wang K; Zheng J; Cheung FS; Chan T; Zhu L; Zhou F
    Pharm Biol; 2014 Dec; 52(12):1510-7. PubMed ID: 25026340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactions of carbamate pesticides with drug transporters.
    Guéniche N; Bruyere A; Ringeval M; Jouan E; Huguet A; Le Hégarat L; Fardel O
    Xenobiotica; 2020 Nov; 50(11):1380-1392. PubMed ID: 32421406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonicotinoid pesticides poorly interact with human drug transporters.
    Le Vée M; Bacle A; Bruyere A; Fardel O
    J Biochem Mol Toxicol; 2019 Oct; 33(10):e22379. PubMed ID: 31364238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid.
    Ren G; Qin Z; Yang N; Chen H; Fu K; Lu C; Lu Y; Li N; Zhang Y; Chen X; Zhao D
    Chem Biol Interact; 2020 Jun; 324():109097. PubMed ID: 32305507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human hepatic drug transporter activity and expression by diesel exhaust particle extract.
    Le Vee M; Jouan E; Stieger B; Lecureur V; Fardel O
    PLoS One; 2015; 10(3):e0121232. PubMed ID: 25803276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
    Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
    Ebner T; Ishiguro N; Taub ME
    J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporter-mediated Natural Product-Drug Interactions.
    Bi Y; Wang X; Ding H; He F; Han L; Zhang Y
    Planta Med; 2023 Feb; 89(2):119-133. PubMed ID: 35304735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines.
    Sayyed K; Camillerapp C; Le Vée M; Bruyère A; Nies AT; Abdel-Razzak Z; Fardel O
    Toxicol In Vitro; 2019 Feb; 54():10-22. PubMed ID: 30189235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical assessment of drug-drug interaction of fb-PMT, a novel anti-cancer thyrointegrin αvβ3 antagonist.
    Fujioka K; Fekry MI; Rumsey JM; Steiner T; Thompson D; Mousa SA
    Clin Transl Sci; 2023 Jun; 16(6):987-1001. PubMed ID: 36967488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters.
    Tátrai P; Schweigler P; Poller B; Domange N; de Wilde R; Hanna I; Gáborik Z; Huth F
    Drug Metab Dispos; 2019 Jul; 47(7):768-778. PubMed ID: 31068368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.